Humana (HUM) Receivables - Other (2009 - 2022)

Humana (HUM) has reported Receivables - Other for 14 consecutive years, with $1.8 billion the latest figure, recorded in Q4 2022.

• On a quarterly basis, Receivables - Other rose 37.31% year-over-year to $1.8 billion in Q4 2022; TTM through Dec 2022 was $1.8 billion, a 37.31% increase from a year earlier, with the FY2022 full-year figure at $1.8 billion, up 37.31% from the prior year.
• Receivables - Other was $1.8 billion for Q4 2022 at Humana, up from $1.3 billion in the prior quarter.
• Over five years, Receivables - Other peaked at $1.8 billion in Q4 2022 and troughed at $1.2 billion in Q4 2020.
• A 5-year average of $1.4 billion and a median of $1.3 billion in 2018 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other retreated 4.89% in 2020 and surged 37.31% in 2022, its largest moves.
• Over 5 years, Receivables - Other stood at $1.3 billion in 2018, then fell by 4.44% to $1.2 billion in 2019, then fell by 4.89% to $1.2 billion in 2020, then increased by 10.87% to $1.3 billion in 2021, then soared by 37.31% to $1.8 billion in 2022.
• The last three Receivables - Other figures came in at $1.8 billion (Q4 2022), $1.3 billion (Q4 2021), and $1.2 billion (Q4 2020), per Business Quant data.